Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma

Serum hepatitis B core-related antigen (HBcrAg) was shown to predict the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients undergoing treatment. We investigated the longitudinal profile of HBcrAg in entecavir (ETV)-treated CHB patients with subsequent HCC development. We i...

Full description

Saved in:
Bibliographic Details
Published in:Gut Liver
Main Authors: Mak, Lung-Yi, Ko, Kwan-Lung, To, Wai-Pan, Wong, Danny Ka-Ho, Seto, Wai-Kay, Fung, James, Yuen, Man-Fung
Format: Artigo
Language:Inglês
Published: Editorial Office of Gut and Liver 2020
Subjects:
Brief Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7492492/
https://ncbi.nlm.nih.gov/pubmed/32457279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19434
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items